CN110446502B - 用于联合非混合使用的含猪病原体的疫苗 - Google Patents

用于联合非混合使用的含猪病原体的疫苗 Download PDF

Info

Publication number
CN110446502B
CN110446502B CN201880022778.9A CN201880022778A CN110446502B CN 110446502 B CN110446502 B CN 110446502B CN 201880022778 A CN201880022778 A CN 201880022778A CN 110446502 B CN110446502 B CN 110446502B
Authority
CN
China
Prior art keywords
vaccine
prrs
pcv
immunogen
infection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201880022778.9A
Other languages
English (en)
Chinese (zh)
Other versions
CN110446502A (zh
Inventor
M.H.维特夫利特
E.范登博恩
M.斯诺
A.A.C.雅各布斯
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Intervet International BV
Original Assignee
Intervet International BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet International BV filed Critical Intervet International BV
Publication of CN110446502A publication Critical patent/CN110446502A/zh
Application granted granted Critical
Publication of CN110446502B publication Critical patent/CN110446502B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CN201880022778.9A 2017-04-13 2018-04-12 用于联合非混合使用的含猪病原体的疫苗 Active CN110446502B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP17166590 2017-04-13
EP17166590.4 2017-04-13
PCT/EP2018/059389 WO2018189290A1 (en) 2017-04-13 2018-04-12 Vaccines containing swine pathogens for associated non-mixed use

Publications (2)

Publication Number Publication Date
CN110446502A CN110446502A (zh) 2019-11-12
CN110446502B true CN110446502B (zh) 2024-01-26

Family

ID=58547447

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201880022778.9A Active CN110446502B (zh) 2017-04-13 2018-04-12 用于联合非混合使用的含猪病原体的疫苗

Country Status (9)

Country Link
US (1) US11311614B2 (cg-RX-API-DMAC10.html)
EP (2) EP4335455A3 (cg-RX-API-DMAC10.html)
JP (2) JP7665289B2 (cg-RX-API-DMAC10.html)
KR (1) KR102724420B1 (cg-RX-API-DMAC10.html)
CN (1) CN110446502B (cg-RX-API-DMAC10.html)
CA (1) CA3058281A1 (cg-RX-API-DMAC10.html)
MX (1) MX390682B (cg-RX-API-DMAC10.html)
RU (1) RU2756767C2 (cg-RX-API-DMAC10.html)
WO (1) WO2018189290A1 (cg-RX-API-DMAC10.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3058281A1 (en) * 2017-04-13 2018-10-18 Intervet International B.V. Vaccines containing swine pathogens for associated non-mixed use
MX2022013080A (es) * 2020-04-20 2022-11-10 Intervet Int Bv Una combinacion de vacunas para el tratamiento profilactico de un cerdo.
US20230241198A1 (en) * 2020-07-24 2023-08-03 Boehringer Ingelheim Animal Health USA Inc. Combination porcine vaccine

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102006884A (zh) * 2008-04-18 2011-04-06 英特威国际有限公司 防御胞内劳森菌、猪肺炎支原体和猪圆环病毒的疫苗

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6042830A (en) * 1992-08-05 2000-03-28 Boehringer Ingelheim Vetmedica, Inc. Viral agent associated with mystery swine disease
WO2002026250A2 (en) * 2000-09-29 2002-04-04 Arizona Board Of Regents On Behalf Of The University Of Arizona Vaccines for proliferative ileitis
CA2587321A1 (en) 2005-01-13 2006-07-20 Boehringer Ingelheim Vetmedica Gmbh Improved prrs vaccines
CN101277717A (zh) 2005-09-09 2008-10-01 英特威国际有限公司 Pcv-2疫苗
CA2635430A1 (en) 2005-12-29 2007-08-23 Boehringer Ingelheim Vetmedica, Inc. Use of a pcv2 immunogenic composition for lessening clinical symptoms in pigs
PT2094872T (pt) 2006-12-15 2017-04-27 Boehringer Ingelheim Vetmedica Inc Tratamento de porcos seropositivos para o anticorpo anti-pcv2 com antigénio de pcv2
US8728487B2 (en) 2011-01-20 2014-05-20 Hua Wu Attenuated live vaccine for prevention of porcine reproductive and respiratory syndrome
UA114503C2 (uk) * 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv та mycoplasma hyopneumoniae
UA114504C2 (uk) * 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs
US9457073B2 (en) 2012-09-26 2016-10-04 University Of Manitoba Live attenuated replication-competent arteriviruses having decreased dub/deisgylating activity
WO2015082457A1 (en) 2013-12-03 2015-06-11 Intervet International B.V. Vaccine against lawsonia intracellularis and porcine circovirus 2
PL3076996T3 (pl) * 2013-12-03 2020-05-18 Intervet International B.V. Szczepionka przeciwko cirkowirusowi świń typu 2
KR102360690B1 (ko) 2013-12-03 2022-02-08 인터벳 인터내셔널 비.브이. Ｐｒｒｓ 및 로소니아 인트라셀룰라리스에 대한 돼지 백신
US20200023128A1 (en) * 2016-12-22 2020-01-23 Intervet Inc. Needleless injector
CA3058281A1 (en) * 2017-04-13 2018-10-18 Intervet International B.V. Vaccines containing swine pathogens for associated non-mixed use

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102006884A (zh) * 2008-04-18 2011-04-06 英特威国际有限公司 防御胞内劳森菌、猪肺炎支原体和猪圆环病毒的疫苗

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Field efficacy study of a novel ready-to-use vaccine against mycoplasma hyopneumoniae and porcine circovirus type 2 in a Greek farm;Eleni D Tzika等;《Porcine Health Manag .》;第1卷(第1期);15 *
Performance of weaned pigs vaccinated with 3FLEX™ compared to pigs vaccinated with Ingelvac® CircoFLEX-MycoFLEX™and Ingelvac® PRRS MLV in separate injections;S Blood等;《 Allen D. Leman Swine Conference》;第263页左栏第2段 *
S Blood等.Performance of weaned pigs vaccinated with 3FLEX™ compared to pigs vaccinated with Ingelvac® CircoFLEX-MycoFLEX™and Ingelvac® PRRS MLV in separate injections.《 Allen D. Leman Swine Conference》.2011,第263页左栏第2段. *

Also Published As

Publication number Publication date
MX390682B (es) 2025-03-21
EP4335455A2 (en) 2024-03-13
KR102724420B1 (ko) 2024-10-30
RU2756767C2 (ru) 2021-10-05
JP2020513027A (ja) 2020-04-30
MX2019012220A (es) 2019-12-09
EP4335455A3 (en) 2024-05-22
JP7665289B2 (ja) 2025-04-21
CA3058281A1 (en) 2018-10-18
RU2019136252A (ru) 2021-05-13
WO2018189290A1 (en) 2018-10-18
RU2019136252A3 (cg-RX-API-DMAC10.html) 2021-05-13
JP2023025210A (ja) 2023-02-21
US20200046825A1 (en) 2020-02-13
CN110446502A (zh) 2019-11-12
EP3609533A1 (en) 2020-02-19
US11311614B2 (en) 2022-04-26
KR20190134650A (ko) 2019-12-04

Similar Documents

Publication Publication Date Title
US10668139B2 (en) Mycoplasma hyopneumoniae vaccine
US20090317423A1 (en) Pcv2 mycoplasma hyopneumoniae immunogenic compositions and methods of producing such compositions
JP6907227B2 (ja) Ｐｃｖ２ウイルス及びマイコプラズマ・ハイオニューモニエ感染症に対する混合ワクチン
HRP20140956A2 (hr) Kombinirano cjepivo protiv pcv, bakterije mycoplasma hyopneumoniae i prrs
TW201828982A (zh) 抗豬小病毒及豬生殖與呼吸道症候群病毒之疫苗及其製造方法
CN105579060A (zh) Pcv2b趋异株疫苗组合物以及使用方法
JP2023025210A (ja) 組合せ非混合使用のためのブタ病原体含有ワクチン
WO2008121958A1 (en) Use of prrsv vaccines to reduce pcv2 viremia
US12594328B2 (en) Combination of vaccines to prophylactically treat a pig
US11654191B2 (en) Vaccine for intradermal application against PCV2 and PRRS virus infection
RU2834834C1 (ru) Комбинация вакцин для профилактического лечения свиней
US10953084B2 (en) Combination vaccine against PCV2 and PRRS virus infection comprising albumin
KR101549744B1 (ko) 돼지 써코바이러스 2형 및 돼지 마이코플라즈마성 폐렴 예방을 위한 혼합백신 조성물

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant